Definium Therapeutics CEO Robert Barrow joins ‘Mad Money’ host Jim Cramer to talk the impact of the recent executive order on breakthrough therpeutic drugs.
Definium Therapeutics CEO Robert Barrow goes one-on-one with Jim Cramer

Source: Cnbc
Read Full Story →



